No single strain or vector is capable of being the best expression option for all types of biopharmaceuticals. The XS Systemâ„¢ ultimately decreases the time of strain screening and design to enable the fast creation of a valuable production strain and efficient cGMP process.
Speaker:
Joachim Klein, Head of Microbial Innovation & Strain Development, Lonza Bioscience